Bioethics Education International (BEI) advances policy and intercultural bioethics debates from the beginning to the end of life.
Who We Are
BEI is a 501c3 tax exempt not-for-profit international organization incorporated in the State of New York, located in Manhattan.
Who will benefit from BEI’s programs and activities?
The organization benefits students, professionals and policy makers from various fields, such as healthcare, the humanities, and the law, as well as policy makers and the public at large. It aims to provide stakeholders with resources to understand and find solutions to issues in global health, health care, new medical technologies, and the life sciences.
How will BEI achieve its educational and outreach purposes?
Through an online bioethics hub, BEI is offering engaging and interactive e-learning courses, webinars, and training sessions. The hub will offer timely topics in bioethics in creative ways, incorporating an interdisciplinary and intercultural approach to confronting ethical issues in medicine, bioscience, medical technology, life sciences, and the environment. BEI provides public access to international bioethics education, facilitates collaborative learning, networking and community debates across the life course around the globe.
News and Articles
Who Gets to Edit the Future?
Scientists are continuing to explore the use of CRISPR gene-editing technology in human embryos to prevent the transmission of inherited genetic diseases. While the research demonstrates the potential to reduce the burden of serious hereditary [...]
Beyond the Outbreak: What Ebola Reveals About Preparedness and Response
A growing Ebola outbreak in Uganda has prompted the Trump administration to reconsider how the United States coordinates its global response. As cases continue to rise, administration officials have discussed appointing a dedicated coordinator while [...]
From Breakthrough to Access: The Next Challenge for HIV Prevention
The new HIV prevention drug lenacapavir is beginning to reach communities in Zambia, offering new hope in the global fight against HIV. Administered just twice a year, the injectable medication has demonstrated near-complete effectiveness in [...]
From Lifelong Management to the Possibility of Cure
A new study published in the New England Journal of Medicine found that bepirovirsen, an experimental hepatitis B treatment, achieved a functional cure in about 1 in 5 patients with chronic hepatitis B after a [...]